HBS1L

HBS1-like protein · Q9Y450 · HBS1L on Sugi Atlas →

0 patent compounds predicted against HBS1L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HBS1L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Intermittent Antimalaria Treatment With SP in African Children PHASE4UNKNOWN
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia PHASE2/PHASE3COMPLETED
Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients PHASE3COMPLETED
Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD) PHASE3COMPLETED
Oxygen Therapy and Pregnancy in Sickle Cell Disease PHASE3COMPLETED
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection PHASE1/PHASE2NOT_YET_RECRUITING
Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA. PHASE1/PHASE2RECRUITING
Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients PHASE1/PHASE2COMPLETED
Transfusion Treatment in Patients With SCD nanCOMPLETED
Hepcidin Levels in Sickle Cell Disease (SCD) nanCOMPLETED
GenoMed4ALL: Improving SCD Classification and Prognosis by AI nanUNKNOWN
Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose nanUNKNOWN
10119473 -VIROMARKERS HDV Biomarkers Study nanNOT_YET_RECRUITING
Sickle Cell Trait in Football Players nanUNKNOWN
Cohort Study of Sickle Cell Patients Evaluating Analgesic Strategies and Their Consequences nanCOMPLETED
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome nanCOMPLETED
Screening for Alpha Thalassemia in Healthy Volunteers nanACTIVE_NOT_RECRUITING
Belgian Antithrombin Deficiency Registry nanNOT_YET_RECRUITING
Hemolysis in Patients With Hereditary Spherocytosis (HS) nanUNKNOWN
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient nanCOMPLETED
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease nanRECRUITING
Red Cell Distribution Width Index Versus Red Cell Distribution Width as Discriminating Guide for Iron Deficiency Anaemia and Beta Thalassemia Trait . nanUNKNOWN
Genetic and Haematological Modifiers of SCD Severity in Kaduna State, Northern Nigeria nanUNKNOWN
Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research nanCOMPLETED
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Cooperative Study of The Clinical Course of Sickle Cell Disease nanCOMPLETED
Impact of Hepatitis B Vaccination on HBs Antigenemia nanCOMPLETED
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HBS1L binder may also engage these)

ProteinNameSimilarity
Q2KHZ2 1.000 Q2KHZ2 →
Q5R6Y0 1.000 Q5R6Y0 →
Q6AXM7 1.000 Q6AXM7 →
Q69ZS7 1.000 Q69ZS7 →
Q9W074 0.994 Q9W074 →
Q5R4B3 0.993 Q5R4B3 →
O74774 0.992 O74774 →
P46199 0.991 P46199 →
Q8R050 0.991 Q8R050 →
GSPT2 Eukaryotic peptide chain release factor GTP-binding subunit ERF3B 0.991 landscape →
P32769 0.990 P32769 →
Q8C0D5 0.990 Q8C0D5 →
O59683 0.989 O59683 →
Q6KAI0 0.989 Q6KAI0 →
TUFM Elongation factor Tu, mitochondrial 0.989 landscape →
KDM5B Lysine-specific demethylase 5B 0.989 landscape →
Q9H1H9 0.988 Q9H1H9 →
Q9HGI4 0.988 Q9HGI4 →
DHX29 ATP-dependent RNA helicase DHX29 0.988 landscape →
P06623 0.988 P06623 →
Q6UB35 0.988 Q6UB35 →
NFKB1 Nuclear factor NF-kappa-B p105 subunit 0.988 landscape →
Q80YE7 0.988 Q80YE7 →
Q5E9U4 0.988 Q5E9U4 →
F4IDQ6 0.988 F4IDQ6 →
DAPK1 Death-associated protein kinase 1 0.988 landscape →
B4NBB0 0.988 B4NBB0 →
P23637 0.988 P23637 →
Q9M3B6 0.988 Q9M3B6 →
O74718 0.987 O74718 →